Search news stories
Enter a keyword to search news.
VivaZome Therapeutics and the University of Adelaide have entered into a series of agreements encompassing licensing of technology, access to stem cells and conduct of research, all in support of VivaZome’s mission to develop and commercialise exosome-based therapeutics.
The University of Adelaide has partnered with medical technology company Sienna Cancer Diagnostics in an exclusive worldwide licence agreement to develop a unique cancer probe with the potential to detect a sugar molecule only present in cancer cells.
French barley breeding company SECOBRA is proud to release its first variety in Australia after many years of collaborative research and development with the University of Adelaide.
Amaero International Limited (ASX:3DA), a world leader in metal additive manufacturing, officially launched their Adelaide facility today in partnership with the University of Adelaide. The facility was opened by the South Australian Minister for Innovation and Skills, the Hon. David Pisoni MP.
The University of Adelaide will introduce a suite of Allied Health degrees to its educational line-up in 2021, enabling students to pursue studies in Physiotherapy, Speech Pathology, or Occupational Therapy at one of Australia’s leading health and medical universities.
Students interested in studying in Melbourne will now have the opportunity to receive a quality University of Adelaide education by studying at the University’s newest campus.
The Adelaide China Biotech Investment Fund has today been launched – a new $45 million investment fund that will accelerate the development and commercialisation of health and bio-technologies from South Australia for the global market.